Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity. Now, new research suggests these medications may also help prevent and treat addiction across a broad range of substances.

Click here to view the original article.